Literature DB >> 2419356

Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.

P Beck-Peccoz, G Piscitelli, S Amr, M Ballabio, M Bassetti, G Giannattasio, A Spada, M Nissim, B D Weintraub, G Faglia.   

Abstract

A 40-yr-old man who had acromegaly and hyperthyroidism due to a GH/TSH-secreting pituitary adenoma is described. Serum free T4 was 2.8 ng/dl, free T3 was 1.1 ng/dl, and TSH was 1.2-1.5 microU/ml; the latter was measured in an immunoradiometric assay with a sensitivity of 0.07 microU/ml. Serum TSH was immunologically identical to standard TSH and did not decrease during a T3 suppression test. Serum free alpha-subunit and the molar alpha-subunit to TSH ratio were high (6.1 ng/ml and 31.2, respectively). TRH administration induced significant increases in both GH (+129%) and alpha-subunit (+156%) levels. Conversely, dopamine infusion resulted in a decrease in serum GH (-66%) and alpha-subunit (-43%) levels, and subsequent administration of the dopamine antagonist sulpiride induced significant increases in both GH and alpha-subunit (+393% and +106%, respectively). Similarly, somatostatin infusion inhibited GH (-43%) and alpha-subunit (-61%) secretion. Serum TSH levels were not affected by TRH, dopamine, or somatostatin. The biological to immunological activity ratio of serum TSH purified by immunoaffinity chromatography and measured in an adenylate cyclase assay was significantly increased compared to that in serum from hypothyroid or euthyroid subjects [biological to immunological activity ratio, 6.9 +/- 0.2 (+/- SD) vs. 4.4 +/- 1.1; P less than 0.001]. In gel chromatography, the apparent mol wt of the patient's TSH was smaller than that of the controls. After adenomectomy, all of the altered parameters of pituitary function became normal. Double gold particle immunostaining of the adenomatous tissue showed that all of the cells contained secretory granules positive for GH and alpha-subunit, while very few cells were positive for TSH beta as well as GH and alpha-subunit. These data indicate that in this patient serum TSH had an apparent mol wt smaller than that of normal TSH and an increased biological activity which, along with the autonomous TSH secretion, account for hyperthyroidism in the presence of low normal TSH levels; alpha-subunit originated from the same adenomatous cells that secreted GH but not TSH, thus explaining the in vivo observation that alpha-subunit responses to several agents were dissociated from TSH responses and parallel to GH responses; and TSH and GH were colocalized in a minority of the neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419356     DOI: 10.1210/jcem-62-4-704

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

2.  Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: the intriguing case of Mister B.

Authors:  L Curtò; M Ragonese; M Losa; F Trimarchi; S Cannavò
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

Review 3.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

Review 4.  Medical management of thyrotropin-secreting pituitary adenomas.

Authors:  Paolo Beck-Peccoz; Luca Persani
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.

Authors:  M Bassetti; M Brina; A Spada; G Giannattasio
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

6.  Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases.

Authors:  T Sano; K Kovacs; S L Asa; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 7.  Molecular pathogenesis of acromegaly.

Authors:  M R Drange; S Melmed
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

8.  Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin.

Authors:  L Persani; M Tonacchera; P Beck-Peccoz; P Vitti; C Mammoli; L Chiovato; R Elisei; G Faglia; M Ludgate; G Vassart
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

Review 9.  Elevated free thyroxine and non-suppressed thyrotropin.

Authors:  Shao Feng Mok; Tze Ping Loh; Byrappa Venkatesh; Doddabele Srinivasa Deepak
Journal:  BMJ Case Rep       Date:  2013-10-28

10.  Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain.

Authors:  P A Dahlberg; P A Petrick; M Nissim; M M Menezes-Ferreira; B D Weintraub
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.